The Patent Finder

Combination PIV3/HMPV RNA Vaccines

ModernaTX, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 14 of these applications claim priority to application PCT/US2016/058327, filed Oct 21, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 10,064,934Combination PIV3/HMPV RNA Vaccines
In force
 · Medium confidence
ModernaTX, Inc.In force
Medium confidence
US 10,272,150Combination PIV3/HMPV RNA Vaccines
In force
 · Low confidence
ModernaTX, Inc.In force
Low confidence
US 10,543,269HMPV RNA Vaccines
In force
 · Low confidence
ModernaTX, Inc.In force
Low confidence
US 10,702,599HPIV3 RNA Vaccines
In force
 · Low confidence
ModernaTX, Inc.In force
Low confidence
US 10,702,600Betacoronavirus Mrna Vaccine
In force
 · Medium confidence
ModernaTX, Inc.In force
Medium confidence
US 10,933,127Betacoronavirus Mrna Vaccine
In force
 · Medium confidence
ModernaTX, Inc.In force
Medium confidence
US 11,872,278Combination Hmpv/Rsv RNA Vaccines
In force
 · Low confidence
ModernaTX, Inc.In force
Low confidence
US 12,208,288Betacoronavirus RNA Vaccines
In force
 · Low confidence
ModernaTX, Inc.In force
Low confidence
US 12,403,335Betacoronavirus Mrna Vaccines
In force
 · Low confidence
ModernaTX, Inc.In force
Low confidence
US 12,403,336BETACORONA VIRUS mRNA VACCINES
In force
 · Low confidence
ModernaTX, Inc.In force
Low confidence
5 more patents in this group · Pro
10 of 15 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 15.
Upgrade to Pro
14 of these are in force and held by ModernaTX, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited